[go: up one dir, main page]

BR9901298A - Novos compostos de benzotiofeno, benzofurano e indol, um processo para sua preparação e composições farmacêuticas que os contêm - Google Patents

Novos compostos de benzotiofeno, benzofurano e indol, um processo para sua preparação e composições farmacêuticas que os contêm

Info

Publication number
BR9901298A
BR9901298A BR9901298-7A BR9901298A BR9901298A BR 9901298 A BR9901298 A BR 9901298A BR 9901298 A BR9901298 A BR 9901298A BR 9901298 A BR9901298 A BR 9901298A
Authority
BR
Brazil
Prior art keywords
group
benzofuran
atom
pharmaceutical compositions
preparation
Prior art date
Application number
BR9901298-7A
Other languages
English (en)
Inventor
Guillaume De Nanteuil
Christine Lila
Tony Verbeuren
Alain Rupin
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of BR9901298A publication Critical patent/BR9901298A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Patente de Invenção: <B>"NOVOS COMPOSTOS DE BENZOTIOFENO, BENZOFURANO E INDOL, UM PROCESSO PARA SUA PREPARAçãO E COMPOSIçõES FARMACêUTICAS QUE OS CONTêM"<D>. Compostos de fórmula geral (I): em que: X representa um átomo de oxigênio, um átomo de enxofre ou um grupo NR3 em que R3 é como definido na descrição, Y representa um átomo de oxigênio, um átomo de enxofre ou um grupo NR3 ou pode representar uma ligação simples quando X representa um grupo NR3, Z representa um átomo de nitrogênio, um átomo de carbono ou um grupo CH, A representa uma ligação simples, um grupo alquileno (opcionalmente substituído), um grupo arileno, um grupo cicloalquileno, um grupo heterocíclico ou um grupo -SO2-R~ 4~-em que R~ 4~ é como definido na descrição, W representa um grupo hidroxila, um grupo alcóxi, um grupo arilóxi, um grupo arilalcóxi, um grupo cicloalcóxi, um heterociclo ligado a um átomo de oxigênio, um grupo amino ou um grupo hidroxiamino, Ra, Rb, Rc ou Rd que podem ser idênticos ou diferentes cada um, independentemente dos outros, são como definido na descrição, R1 representa um grupo arila substituído por de um a cinco substituintes idênticos ou diferentes, cada um independentemente dos outros, uma heteroarila opcionalmente substituída ou um grupo como definido para fórmula (I).
BR9901298-7A 1998-04-27 1999-04-27 Novos compostos de benzotiofeno, benzofurano e indol, um processo para sua preparação e composições farmacêuticas que os contêm BR9901298A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9805239A FR2777886B1 (fr) 1998-04-27 1998-04-27 Nouveaux derives benzothiopheniques, benzofuraniques et indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
BR9901298A true BR9901298A (pt) 2000-05-02

Family

ID=9525701

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9901298-7A BR9901298A (pt) 1998-04-27 1999-04-27 Novos compostos de benzotiofeno, benzofurano e indol, um processo para sua preparação e composições farmacêuticas que os contêm

Country Status (17)

Country Link
US (1) US6048875A (pt)
EP (1) EP0955299B1 (pt)
JP (1) JP3957424B2 (pt)
CN (1) CN1211362C (pt)
AT (1) ATE214387T1 (pt)
AU (1) AU744456B2 (pt)
BR (1) BR9901298A (pt)
CA (1) CA2270086C (pt)
DE (1) DE69901006T2 (pt)
DK (1) DK0955299T3 (pt)
ES (1) ES2174579T3 (pt)
FR (1) FR2777886B1 (pt)
HU (1) HUP9901403A1 (pt)
NO (1) NO319101B1 (pt)
NZ (1) NZ335388A (pt)
PT (1) PT955299E (pt)
ZA (1) ZA992941B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162930A (en) 1998-03-06 2000-12-19 Baylor University Anti-mitotic agents which inhibit tubulin polymerization
FR2799756B1 (fr) * 1999-10-15 2001-12-14 Adir Nouveaux derives benzothiopheniques, benzofuraniques et indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU4352701A (en) * 2000-03-10 2001-09-24 Univ Baylor Tubulin binding ligands and corresponding prodrug constructs
EP1390030A1 (en) * 2001-05-31 2004-02-25 Cellegy Pharmaceuticals, Inc Store operated calcium influx inhibitors and methods of use
PT1397130E (pt) 2001-06-20 2007-11-13 Wyeth Corp Derivados ácidos de indole substituído como inibidores de inibidor 1 do activador de plasminogénio (pai-1)
TWI224101B (en) 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
EP1569901B1 (en) * 2002-12-10 2008-10-15 Wyeth ARYL, ARYLOXY, AND ALKYLOXY SUBSTITUTED i 1H /i -INDOL-3-YL GLYOXYLIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
JP2006514640A (ja) * 2002-12-10 2006-05-11 ワイス プラスミノゲンアクティベータインヒビターのインヒビターとしての置換3−アルキル及び3−アリールアルキル1h−イル酢酸誘導体
MXPA05006288A (es) * 2002-12-10 2005-08-19 Wyeth Corp Derivados del acido 3-carbonil-1h-indol-1-ilacetico sustituidos como inhibidores del inhibidor del activador de plasminogeno 1 (pai-1).
CA2509222A1 (en) * 2002-12-10 2004-06-24 Wyeth Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
UA80453C2 (en) * 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
US7268159B2 (en) 2003-09-25 2007-09-11 Wyeth Substituted indoles
US7411083B2 (en) 2003-09-25 2008-08-12 Wyeth Substituted acetic acid derivatives
US7141592B2 (en) 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
US7582773B2 (en) 2003-09-25 2009-09-01 Wyeth Substituted phenyl indoles
US7265148B2 (en) 2003-09-25 2007-09-04 Wyeth Substituted pyrrole-indoles
US7446201B2 (en) 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7342039B2 (en) 2003-09-25 2008-03-11 Wyeth Substituted indole oximes
US7332521B2 (en) 2003-09-25 2008-02-19 Wyeth Substituted indoles
US7420083B2 (en) 2003-09-25 2008-09-02 Wyeth Substituted aryloximes
US7534894B2 (en) 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
US7351726B2 (en) 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
US7163954B2 (en) 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
US7442805B2 (en) * 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
JP2008510815A (ja) 2004-08-23 2008-04-10 ワイス 血栓症および心臓血管疾患の治療にて有用な調節剤であるプラスミノゲン活性化因子阻害剤1型(pai−1)としてのオキサゾロ−ナフチル酸
WO2006023866A2 (en) * 2004-08-23 2006-03-02 Wyeth Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
BRPI0514549A (pt) * 2004-08-23 2008-06-17 Wyeth Corp ácidos de pirrol-naftila como inibidores de pai-1
CN101263115A (zh) 2005-08-17 2008-09-10 惠氏公司 经取代吲哚和其用途
AU2007286807B2 (en) * 2006-08-21 2013-03-21 Genentech, Inc. Aza-benzothiophenyl compounds and methods of use
ATE531720T1 (de) * 2006-08-21 2011-11-15 Genentech Inc Aza-benzofuranylverbindungen und anwendungsverfahren dafür

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663344A (en) * 1985-03-11 1987-05-05 Merck & Co., Inc. Anti-inflammatory and analgesic 3-hydroxybenzo[b]thiophene derivatives, compositions, and method of use therefor
IT1227362B (it) * 1988-11-18 1991-04-08 Istituto Biochimico Italiano Derivati indolici, processo per la loro preparazione e loro uso comefarmaci antitrombotici
US5356926A (en) * 1992-02-24 1994-10-18 Warner-Lambert Company 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo [β]thiophene-2-carboxamides as inhibitors of cell adhesion

Also Published As

Publication number Publication date
CN1211362C (zh) 2005-07-20
AU2402199A (en) 1999-11-04
NO991957L (no) 1999-10-28
DE69901006D1 (de) 2002-04-18
CA2270086C (fr) 2005-04-05
JP3957424B2 (ja) 2007-08-15
NO319101B1 (no) 2005-06-20
HK1022694A1 (en) 2000-08-18
CN1235156A (zh) 1999-11-17
FR2777886A1 (fr) 1999-10-29
JPH11349586A (ja) 1999-12-21
CA2270086A1 (fr) 1999-10-27
US6048875A (en) 2000-04-11
ZA992941B (en) 1999-10-26
EP0955299B1 (fr) 2002-03-13
NO991957D0 (no) 1999-04-23
DK0955299T3 (da) 2002-06-24
HUP9901403A1 (hu) 2000-06-28
ATE214387T1 (de) 2002-03-15
NZ335388A (en) 2000-03-27
DE69901006T2 (de) 2002-11-07
EP0955299A1 (fr) 1999-11-10
ES2174579T3 (es) 2002-11-01
FR2777886B1 (fr) 2002-05-31
HU9901403D0 (en) 1999-06-28
PT955299E (pt) 2002-07-31
AU744456B2 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
BR9901298A (pt) Novos compostos de benzotiofeno, benzofurano e indol, um processo para sua preparação e composições farmacêuticas que os contêm
AR004219A1 (es) Nuevos derivados de quinazolina, procedimientos para su preparacion, composiciones que los contienen y su uso en la preparacion de medicamentos,particularmente en el tratamiento de trastornos inflamatorios
BR9907429A (pt) Composto de hidrazida, processo para sua preparação e composições farmacêuticas contendo os mesmos
BR9911783A (pt) Compostos cìclicos substituìdos, processo para sua preparação e composições farmacêuticas que os contêm
BR9912621A (pt) Derivado de ácido aminometilcarboxìlico, composição farmacêutica, e, uso de um derivado de ácido aminometilcarboxìlico
PE20050142A1 (es) 2-hidroxi-3-diaminoalcanos de benzamida
BR0307409A (pt) Compostos de hidrazida de ácido 2-furanocarboxìlico, composições farmacêuticas contendo os mesmos e uso dos mesmos para preparação de um agente preventivo ou terapêutico
ATE282025T1 (de) Inhibitoren von c-amp phosphodiesterase
BRPI0515524A (pt) compostos quìmicos
BR0005171A (pt) Compostos benzotiofeno, benzofurano e indol, processo para a preparação dos mesmos e composições farmacêuticas contendo os mesmo
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BR9812793A (pt) Antagonistas do receptor de trombina
KR890002121A (ko) 신규 벤조피란 유도체, 그의 제조방법 및 이를 함유하는 제약학적 조성물
AR041883A1 (es) Compuestos de piridopirimidinona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
BR0113425A (pt) Aminoalquilbenzoil-benzofuranos ou benzotiófenos, processo de preparação dos mesmos e as composições que os contêm
BR9916669A (pt) Uso de derivados de ácidos 4-biarilbutìricos e 5-biarilpentanóicos substituìdos como inibidores de metaloproteases de matriz para o tratamento de doenças respiratórias
BR9712707A (pt) Derivados de ácido 4-bifenil-4-hidroxibutìrico substituìdo com inibidores de metaloprotease de matriz
DK441180A (da) 2-hydroxyalkyl-3,4,5-trihydroxypiperidiner deres fremstilling og anvendelse
DK161319C (da) Dihydroxyquinoxalinforbindelser, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar
ATE93863T1 (de) Enzym-hemmende aminosaeurederivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung.
AR018632A1 (es) Compuestos derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene, proceso para su preparacion.
BR0004823A (pt) Compostos policìclicos de azaindol, processo para a preparação dos mesmos e composições farmacêuticas contendo os mesmos
BR9813217A (pt) Tetraciclos, processo para a produção dos mesmos e preparações farmacêuticas contendo estes compostos
BRPI0415109A (pt) compostos de 1-[2-(4-hidroxifenil)-2-hidroxietil]-piperidin-4-ol como antagonistas de receptor de nmda
BR9801448A (pt) Compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos.

Legal Events

Date Code Title Description
PC Transfer

Free format text: LES LABORATOIRES SERVIER (FR)

B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: COM A PETICAO NO 021360, DE 26/04/2002, A REQUERENTE SOLICITOU O EXAME DO PRESENTE PEDIDO, JUNTAMENTE COM NOVAS VIAS DO QUADRO REIVINDICATORIO ( TOTAL DE 23 REIVINDICACOES ). NO ENTANTO, NA PETICAO SUPRACITADA E INDICADO O PAGAMENTO RELATIVO A 22 REIVINDICACOES. DESSE MODO, A FIM DE DAR CONTINUIDADE AO EXAME DO PEDIDO, A REQUERENTE DEVERA COMPLEMENTAR A RETRIBUICAO EQUIVALENTE A 01 ( UMA ) REIVINDICACAO EXCEDENTE

B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]